120 related articles for article (PubMed ID: 18946891)
1. Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter study.
Schou M; Gustafsson F; Videbaek L; Markenvard J; Ulriksen H; Ryde H; Jensen JC; Nielsen T; Knudsen AS; Tuxen CD; Handberg J; Sørensen PJ; Espersen G; Lind-Rasmussen S; Keller N; Egstrup K; Nielsen OW; Abdulla J; Nyvad O; Toft J; Hildebrandt PR
Am Heart J; 2008 Oct; 156(4):649-55. PubMed ID: 18946891
[TBL] [Abstract][Full Text] [Related]
2. Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar).
Schou M; Gustafsson F; Videbaek L; Tuxen C; Keller N; Handberg J; Sejr Knudsen A; Espersen G; Markenvard J; Egstrup K; Ulriksen H; Hildebrandt PR;
Eur Heart J; 2013 Feb; 34(6):432-42. PubMed ID: 22875412
[TBL] [Abstract][Full Text] [Related]
3. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal pro-B-type natriuretic peptide measurement.
Troughton RW; Richards AM
Am J Cardiol; 2008 Feb; 101(3A):72-5. PubMed ID: 18243863
[TBL] [Abstract][Full Text] [Related]
4. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure.
Zhang J; Pellicori P; Pan D; Dierckx R; Clark AL; Cleland JGF
Int J Cardiol; 2018 Oct; 269():196-200. PubMed ID: 30001941
[TBL] [Abstract][Full Text] [Related]
5. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
[TBL] [Abstract][Full Text] [Related]
6. Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study).
Schou M; Gustafsson F; Videbaek L; Andersen H; Toft J; Nyvad O; Ryde H; Fog L; Jensen JC; Nielsen OW; Lind-Rasmussen S; Abdulla J; Hildebrandt PR;
Eur J Heart Fail; 2013 Jul; 15(7):818-27. PubMed ID: 23507787
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
11. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
12. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical variation of NT-proBNP in stable chronic heart failure patients.
Schou M; Gustafsson F; Kjaer A; Hildebrandt PR
Eur Heart J; 2007 Jan; 28(2):177-82. PubMed ID: 17218450
[TBL] [Abstract][Full Text] [Related]
15. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
[TBL] [Abstract][Full Text] [Related]
17. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
[TBL] [Abstract][Full Text] [Related]
19. Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).
Zhang S; Hu Y; Zhou L; Chen X; Wang Y; Wu J; He H; Gao Y
Arch Gerontol Geriatr; 2015; 60(2):359-65. PubMed ID: 25466512
[TBL] [Abstract][Full Text] [Related]
20. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
